Grey Healthcare Group expands speciality market expertise
29 November, 2006
Grey Healthcare Group (GHG), a WPP company, has acquired Vogel·Farina, a New Jersey-based strategic marketing and communications company with significant expertise in specialty Rx markets, particularly oncology. According to IMS Health, the worldwide oncology market is estimated to reach $40 to $50 billion in 2007.
The acquisition of Vogel·Farina is part of GHG’s drive to expand its specialty marketing footprint. GHG now has several agencies specializing in biotech and specialty products, including the NY-based Acute and Specialty Care division, UK-based DarwinGrey, and Germany-based s&kGrey.
Vogel·Farina’s business model is built around a strong core of strategic consulting services. The company provides strategic business/market planning and analysis, product and corporate positioning and branding, promotional planning and tactical implementation services to a wide range of clients in the pharmaceutical, biotech, and medical-device industries. In addition to oncology, Vogel·Farina’s category expertise includes infectious disease, CNS, cardiovascular, diabetes, medical device, and diagnostic products.
“Vogel·Farina is a strategic powerhouse. Founders Bob and Jeff have a wealth of experience launching brands in specialty care and oncology,” said Lynn O’Connor Vos, CEO, GHG. “That experience, combined with their deep market insights, makes them an important addition to the company.”
Vogel·Farina will continue to be managed by co-presidents Bob Vogel and Jeff Farina.
“We are extremely excited about being part of GHG,” said Farina. “We look forward to bringing a much broader and deeper array of services to our client base, including access to one of the most robust global networks in the healthcare advertising and communications sector.”